Priority Date: 31.08.12 (US 201261695409P)

MONOCLONAL ANTIBODIES FOR ENHANCING OR INHIBITING INSULIN-LIKE GROWTH FACTOR 1 (IGF-1)

  • Application ID: EP13832446
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This patent has the IPC combination A61, C07, and C12 is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 128 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 31.08.2012 - Priority Date (US 201261695409P)
  • 06.03.2014 - Publication A1 (WO2014036385)
  • 08.07.2015 - Publication A1 (EP2890716)

IPC Classification